Aortobifemoral bypass surgery is used to bypass diseased large
blood vessels in the abdomen and groin.
To bypass the blocked blood vessel, blood is redirected through a
graft made of synthetic material (such as polytetrafluoroethylene [PTFE] or
Dacron). This graft is sewn above and below the diseased artery so that blood
flows through the graft. These man-made grafts are more likely to be used than
transplanted natural grafts for aortobifemoral surgery, because the blood
vessels involved are large.
The artificial blood vessel is formed into a Y shape. The single
end of the Y is sewn on the aorta. The two split ends of the Y are sewn below
the blocked or narrowed areas of the femoral arteries. This allows the blood to
travel around (bypass) the diseased areas. See a picture of
General anesthesia is used and will cause you to sleep through the
You will likely stay in the hospital 4 to 7 days. And you can expect your belly and groin to be sore for several weeks. You will probably feel more tired than usual for several weeks.
You may be able to do many of your usual activities after 4 to 6 weeks. But you will likely need 2 to 3 months to fully recover, especially if you typically do a lot of physical activities.
You will probably need to take at least 4 to 6 weeks off from work. It depends on the type of work you do and how you feel.
Aortobifemoral bypass surgery is for people who have blocked blood
vessels (aorta or iliac arteries) in the abdomen and pelvis. The blockage
usually must be causing significant symptoms or be limb-threatening before
bypass surgery is considered.
Aortobifemoral bypass grafts stay open about 90% of the time for at
least 5 years.1
All surgeries carry a certain amount of risk. These risks include:
Specific risks for aortobifemoral bypass surgery include:
For help deciding whether to have surgery, see:
Complete the surgery information form (PDF)(What is a PDF document?) to help you prepare for this surgery.
CitationsHirsch AT, et al. (2006). ACC/AHA 2005 practice
guidelines for the management of patients with peripheral arterial disease
(lower extremity, renal, mesenteric, and abdominal aortic): A collaborative
report from the American Association for Vascular Surgery/Society for Vascular
Surgery, Society for Cardiovascular Angiography and Interventions, Society for
Vascular Medicine and Biology, Society of Interventional Radiology, and the
ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop
Guidelines for the Management of Patients With Peripheral Arterial Disease):
Endorsed by the American Association of Cardiovascular and Pulmonary
Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular
Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease
Foundation. Circulation, 113(11): e463–e654.
October 14, 2011
Rakesh K. Pai, MD, FACC - Cardiology, Electrophysiology & David A. Szalay, MD - Vascular Surgery
How this information was developed to help you make better health decisions.
To learn more visit Healthwise.org
© 1995-2013 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.